Maximal androgen blockade for the treatment of metastatic prostate cancer—a systematic review

por Lukka, H., Waldron, T., Klotz, L., Winquist, E., Trachtenberg, J.
Publicado 2006

Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment

por Da Rosa, M.R., Trachtenberg, J., Chopra, R., Haider, M.A.
Publicado 2011

Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase

por Lu, J P, Monardo, L, Bryskin, I, Hou, Z F, Trachtenberg, J, Wilson, B C, Pinthus, J H
Publicado 2009

The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer

por Akbari, M R, Wallis, C J D, Toi, A, Trachtenberg, J, Sun, P, Narod, S A, Nam, R K
Publicado 2014

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer

por Nam, R K, Sugar, L, Yang, W, Srivastava, S, Klotz, L H, Yang, L-Y, Stanimirovic, A, Encioiu, E, Neill, M, Loblaw, D A, Trachtenberg, J, Narod, S A, Seth, A
Publicado 2007